Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY
Sarah A. Spinler(Unknown), Robert M. Califf(Duke University), Sunil V. Rao(New York University), Elliott M. Antman(Brigham and Women's Hospital), Glenn N. Levine(American College of Cardiology), Kenneth W. Mahaffey(Cardiovascular Institute of the South), Shaun G. Goodman(University of Toronto), John Ducas(St. Boniface Hospital), Dianne Gallup(Clinical Research Institute), Marc Cohen(Newark Beth Israel Medical Center), Richard L. Gallo(University of California San Diego), Robert A. Harrington(Clinical Research Institute), Harvey D. White(University of Auckland), James J. Ferguson(Brigham and Women's Hospital), Richard C. Becker(University of Cincinnati), Jacques Col(Cliniques Universitaires Saint-Luc), Luigi M. Biasucci(Agostino Gemelli University Polyclinic)
Cited by 25
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k